Clinical Trial Update: Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating cordycepin for treating CD8+ lymphocytopenia in patients with solid tumors and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphopenia
• Solid Tumors

Drugs mentioned

• Cordycepin (cordycepin)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Solid Cancer, Lymphopenia | Phase 2 | Status: RECRUITING